Mats Remberger

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

European journal of haematology

Transplant infectious disease : an official journal of the Transplantation Society

The European journal of health economics : HEPAC : health economics in prevention and care

International journal of hematology

Uppsala University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uppsala University Hospital Mar 01 2018

Sweden

Researcher :: KFUE

Publications

Tommy Alfaro Moya, Jonas Mattsson, Mats Remberger, Jeffrey Howard Lipton, Dennis Dong Hwan Kim, Auro Viswabandya, Rajat Kumar, Wilson Lam, Arjun Datt Law, Armin Gerbitz, Ivan Pasic, Igor Novitzky-Basso, Fotios V Michelis
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission. European journal of haematology (2023)
Ian Pang, Peggy Chen, Gertrude V Trinh, Mats Remberger, Igor Novitzky-Basso, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun D Law, Jeffrey Howard Lipton, Auro Viswabandya, Ivan Pasic, Jonas Mattsson, Fotios V Michelis
Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data. European journal of haematology (2023)
Shruti Prem, Mats Remberger, Ahmad S Alotaibi, Wilson Lam, Arjun Datt Law, Dennis Dong Hwan Kim, Fotios V Michelis, Zeyad Al-Shaibani, Jeffrey Howard Lipton, Jonas Mattsson, Auro Viswabandya, Rajat Kumar, Cynthia Ellison
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society 24 (4) (2022)
Alejandro Garcia-Horton, Sunu L Cyriac, Tobias Gedde-Dahl, Yngvar Fløisand, Mats Remberger, Jonas Mattsson, Fotios V Michelis
Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups. European journal of haematology 109 (6) (2022)
Igor Novitzky-Basso, Mats Remberger, Carol Chen, Cynthia Ellison, Ivan Pasic, Wilson Lam, Arjun Law, Armin Gerbitz, Auro Viswabandya, Jeffrey Howard Lipton, Dennis Dong Hwan Kim, Rajat Kumar, Fotios V Michelis, Jonas Mattsson
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors. European journal of haematology 108 (4) (2021)
Igor Novitzky-Basso, Mats Remberger, Carol Chen, Ivan Pasic, Wilson Lam, Arjun Law, Armin Gerbitz, Auro Viswabandya, Jeffrey Howard Lipton, Dennis D Kim, Rajat Kumar, Jonas Mattsson, Fotios V Michelis
Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts. European journal of haematology 108 (1) (2021)
Frida Schain, Nurgul Batyrbekova, Johan Liwing, Simona Baculea, Thomas Webb, Mats Remberger, Jonas Mattsson
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease. The European journal of health economics : HEPAC : health economics in prevention and care 22 (1) (2020)
Mats Remberger, Johan Törlen, Ibrahim El Serafi, Karin Garming-Legert, Andreas Björklund, Per Ljungman, Mikael Sundin, Moustapha Hassan, Jonas Mattsson
Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation. International journal of hematology 106 (4) (2017)

Mats Remberger.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mats Remberger